Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | August 05, 2026 | August 14, 2026 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Director · Chief Executive Officer | February 27, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date August 05, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 27,583 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 27,583 |
Bausch Health Companies Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 2,315,374 |
Ending reported balance
After 2026-03-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-02-27 · Tax withholding · Disposed 83,093 · Balance 3,536,941 F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 2 · 2026-03-02 · Tax withholding · Disposed 83,705 · Balance 3,453,236 F2: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 3 · 2026-03-02 · Other · Disposed 1,137,862 · Balance 2,315,374 F3: Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F2: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F3: Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2021 Filed Mar 5, 2021 22:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 32,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009559 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,601 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 5,436 | $31.42 | $170,799.12 |
DisclosureSEC source: 0001127602-21-009144 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,975 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 3,224 | $20.61 | $66,446.64 |
DisclosureSEC source: 0001127602-20-031885 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,411 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 09, 2020 Filed Mar 12, 2020 00:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,734 | $20.96 | $57,304.64 |
DisclosureSEC source: 0001127602-20-010320 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,635 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,796 | $24.44 | $68,334.24 |
DisclosureSEC source: 0001127602-20-009081 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,369 F1 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 81,873 | $0.00 Strike: $24.77 | $0.00 |
DisclosureSEC source: 0001127602-20-008434 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,873 Underlying: Common Shares, No Par Value · 81,873 shares Expires 2030-02-26 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 19,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008434 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,165 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 02:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 9,866 | $26.46 | $261,054.36 |
DisclosureSEC source: 0001127602-20-007077 · form4.xml · nonDerivative · entry 3 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,716 F4 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 02:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 3,932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-007077 · form4.xml · derivative · entry 4 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F3 · price: Each PSU converts into Common Shares on a one-for-one basis. F2 · derivative.exercise_date: On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics. F2 · derivative.expiration_date: On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 4 filed on January 10, 2017 with the maximum potential award amount of 8,192 shares. Any portion of the award not vested on February 19, 2020 was cancelled as of that date. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 02:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 21,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007077 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,582 Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 02:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Stock, No Par Value | 3,932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-007077 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person in connection with the vesting of performance-based Restricted Share Units ("PSUs") granted to the reporting person on January 6, 2017. F2 · shares: On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics. F3 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 21:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 1,827 | $29.42 | $53,750.34 |
DisclosureSEC source: 0001127602-20-001366 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,517 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 00:20 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 3,337 | $31.00 | $103,447.00 |
DisclosureSEC source: 0001127602-19-035273 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,344 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 20:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 8,362 | $21.30 | $178,110.60 |
DisclosureSEC source: 0001127602-19-027165 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,681 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 2,907 | $23.56 | $68,488.92 |
DisclosureSEC source: 0001127602-19-011029 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,043 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:01 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 62,004 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009234 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,004 Underlying: Common Shares, No Par Value · 62,004 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:01 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 21,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009234 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,950 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:04 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 1,722 | $21.25 | $36,592.50 |
DisclosureSEC source: 0001127602-19-001761 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,640 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 21:22 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 25,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-036571 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,362 F2 · shares: Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported above (the "Purchased Shares"), pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant ("MRSU Grant Date"), subject to the Reporting Person's continued service (except in limited circumstances). Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 21:22 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, No Par Value | 25,440 | $22.96 | $584,018.45 |
DisclosureSEC source: 0001127602-18-036571 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,922 F1 · shares: The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $22.94 to $22.96 per share. Upon request by the Commission staff, the Issuer or the reporting person will provide full information regarding the number of Common Shares purchased by the reporting person at each separate price within the range set forth in this footnote. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 20:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 5,501 | $21.69 | $119,316.69 |
DisclosureSEC source: 0001127602-18-026009 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,585 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| August 20, 2018 Filed Sep 18, 2018 20:31 UTC Amendment | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 6,604 | $21.69 | $143,240.76 |
DisclosureSEC source: 0001127602-18-027894 · form4a.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,482 F1 · shares: This Form 4/A is being filed to correct the number of shares withheld to satisfy the tax withholding obligations due upon the vesting of Restricted Share Units. Read SEC document |
| March 07, 2018 Filed Mar 10, 2018 01:56 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantRestricted Share Units · Derivative | 14,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-011038 · form4.xml · derivative · entry 3 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,776 Underlying: Common Stock · 14,776 shares Expires 2021-03-07 F3 · derivative.exercise_price: Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 7,388 and the maximum number that can be distributed is 14,776. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return ("TSR") as measured for the 20 trading days preceding the TSR Measurement Date ("Measurement Date") which is the third anniversary of the grant date (March 7, 2021). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group based on the 20 trading days preceding the Measurement Date, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award. F3 · derivative.exercise_date: Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 7,388 and the maximum number that can be distributed is 14,776. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return ("TSR") as measured for the 20 trading days preceding the TSR Measurement Date ("Measurement Date") which is the third anniversary of the grant date (March 7, 2021). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group based on the 20 trading days preceding the Measurement Date, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award. Read SEC document |
| March 07, 2018 Filed Mar 10, 2018 01:56 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 65,923 | $0.00 Strike: $15.32 | $0.00 |
DisclosureSEC source: 0001127602-18-011038 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,923 Underlying: Common Shares, No Par Value · 65,923 shares Expires 2028-03-07 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 07, 2018 Filed Mar 10, 2018 01:56 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 22,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-011038 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,086 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Valeant Pharmaceuticals International, Inc. ("Valeant"). Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 20:27 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 1,557 | $23.85 | $37,134.45 |
DisclosureSEC source: 0001127602-18-001435 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,631 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| January 08, 2018 Filed Jan 29, 2018 15:32 UTC Amendment | Bausch Health Companies Inc. VRX · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 1,264 | $23.85 | $30,146.40 |
DisclosureSEC source: 0001127602-18-002719 · form4a.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,924 F1 · shares: This Form 4/A is being filed to correct the number of shares withheld to satisfy the tax withholding obligations due upon the vesting of Restricted Share Units. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 20:37 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 5,687 | $14.15 | $80,471.05 |
DisclosureSEC source: 0001127602-17-026209 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,188 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| May 10, 2017 Filed May 11, 2017 20:56 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 3,274 | $9.71 | $31,790.54 |
DisclosureSEC source: 0001127602-17-017764 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,875 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 28, 2017 Filed Mar 30, 2017 21:30 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, no par value | 63,742 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-17-000019 · primary_doc.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,149 F1 · shares: Represents the award of Restricted Share Units (RSUs) which will vest one-third (1/3) on August 17, 2017, one-third (1/3) on August 17, 2018 and one-third (1/3) on August 17, 2019. Vested RSUs are settled in common shares, no par value (Common Shares), of Valeant Pharmaceuticals International, Inc. (Valeant). Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 22:41 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 30,174 | $0.00 Strike: $14.38 | $0.00 |
DisclosureSEC source: 0001681871-17-000007 · primary_doc.xml · derivative · entry 1 APPIO THOMAS · CIK 0001683323 · EVP, COMPANY GROUP CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,174 Underlying: Common Shares, no par value · 30,174 shares Expires 2027-03-01 F1 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| January 06, 2017 Filed Jan 11, 2017 00:12 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantRestricted Share Units · Derivative | 8,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001681871-17-000005 · primary_doc.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · EVP, Company Groupo Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,192 Underlying: Common Stock · 8,192 shares Expires 2020-01-06 F3 · derivative.exercise_price: Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 4,096 and the maximum number that can be distributed is 8,192. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return ("TSR") as measured on January 6, 2020 (the "Measurement Date"). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award. F3 · derivative.exercise_date: Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 4,096 and the maximum number that can be distributed is 8,192. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return ("TSR") as measured on January 6, 2020 (the "Measurement Date"). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award. Read SEC document |
| January 06, 2017 Filed Jan 11, 2017 00:12 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, no par value | 12,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001681871-17-000005 · primary_doc.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · EVP, Company Groupo Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,407 F1 · shares: Represents the award of Restricted Share Units ("RSUs") which will vest one-third on each of the three anniversaries following the date of grant, subject to the reporting person's continued service subject to continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Valeant Pharmaceuticals International, Inc. ("Valeant"). F2 · balance_after: The total number of shares excludes the 25,425 performance-vesting RSUs previously included in Column 2 of the reporting person's Form 3 filed on September 1, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.